JP2006517032A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517032A5
JP2006517032A5 JP2006503077A JP2006503077A JP2006517032A5 JP 2006517032 A5 JP2006517032 A5 JP 2006517032A5 JP 2006503077 A JP2006503077 A JP 2006503077A JP 2006503077 A JP2006503077 A JP 2006503077A JP 2006517032 A5 JP2006517032 A5 JP 2006517032A5
Authority
JP
Japan
Prior art keywords
tfrscfv
complex
gemzar
kda
caspase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006503077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/002261 external-priority patent/WO2004066946A2/en
Publication of JP2006517032A publication Critical patent/JP2006517032A/ja
Publication of JP2006517032A5 publication Critical patent/JP2006517032A5/ja
Pending legal-status Critical Current

Links

JP2006503077A 2003-01-28 2004-01-28 ある種の癌治療の有効性を評価するための方法 Pending JP2006517032A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44290203P 2003-01-28 2003-01-28
PCT/US2004/002261 WO2004066946A2 (en) 2003-01-28 2004-01-28 Method for evaluating the efficacy of certain cancer treatments

Publications (2)

Publication Number Publication Date
JP2006517032A JP2006517032A (ja) 2006-07-13
JP2006517032A5 true JP2006517032A5 (https=) 2007-03-15

Family

ID=32825276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006503077A Pending JP2006517032A (ja) 2003-01-28 2004-01-28 ある種の癌治療の有効性を評価するための方法

Country Status (5)

Country Link
US (1) US20040241088A1 (https=)
EP (1) EP1595142A4 (https=)
JP (1) JP2006517032A (https=)
CA (1) CA2513769A1 (https=)
WO (1) WO2004066946A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617514B2 (en) 1999-02-22 2013-12-31 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
AU2006304790B2 (en) * 2005-10-20 2013-06-27 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
CN102325719A (zh) 2008-12-30 2012-01-18 3M创新有限公司 纳米结构化制品和制备纳米结构化制品的方法
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
WO2020117715A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment
JPWO2022075439A1 (https=) * 2020-10-08 2022-04-14

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462175B1 (en) * 1995-11-13 2002-10-08 Thomas Jefferson University Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use
AU759164C (en) * 1997-11-19 2007-03-29 Georgetown University Targeted liposome gene delivery
ATE511543T1 (de) * 1999-02-22 2011-06-15 Univ Georgetown Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
US6391575B1 (en) * 1999-03-05 2002-05-21 Idun Pharmaceuticals, Inc. Methods for detecting membrane derived caspase activity and modulators thereof
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide

Similar Documents

Publication Publication Date Title
Liang et al. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat
Long et al. Downregulation of MCT 4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
Lee et al. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
HU229263B1 (en) The use of pharmaceutical compositions containing 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation
Bi et al. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
US20180221369A1 (en) Compositions and methods for treating fibrosing disorders and cancer
JP2023546579A (ja) がん治療のためのフェロトーシスの誘導
Sugimoto et al. Apoptosis‐promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin In vitro and In vivo
Gao et al. Influence of chk1 and plk1 silencing on radiation-or cisplatin-induced cytotoxicity in human malignant cells
US20210069330A1 (en) Methods and compositions for tumor radiosensitization
US8740762B2 (en) Specific inhibition of cPLA2 enhances the efficacy of radiotherapy
JP2006517032A5 (https=)
US20100239596A1 (en) Grp78 and tumor angiogenesis
JP5762103B2 (ja) 頭頸部癌及び食道癌用抗癌剤及び増強剤
KR101191958B1 (ko) Tle1 억제제를 유효성분으로 함유하는 활액막 육종 예방 및 치료용 약학적 조성물
KR20230055998A (ko) 암 치료 또는 예방용 조성물
US20040241088A1 (en) Method for evaluating the efficacy of certain cancer treatments
US20070154457A1 (en) Use of eIF-5A to kill multiple myeloma cells
US8129356B2 (en) Bmx mediated signal transduction in irradiated vascular endothelium
AU2013206284A1 (en) Use of eif-5a to kill multiple myeloma cells
US20050043262A1 (en) Novel specific inhibitor of the cyclin kinase inhibitor p21Waf1/Cip1 and methods of using the inhibitor
CN121731344A (zh) 一种增强肝癌免疫治疗疗效的外泌体囊泡及其制备方法和应用
Miyauchi The Role of Neuropilin 1 in Glioma Associated Microglia and Macrophages
CN101568347A (zh) eIF-5A在杀死多发性骨髓瘤细胞上的用途
Ginsberg et al. Franco DeMonte, Chrisstopher G. Kalhorn (Houston, TX)